Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Digestizyme capsules
091102000BBIIA0
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
FSC Co-Q-10 30mg capsules
091102000BBGLAI
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
G & G CoQ10 100mg capsules
091102000BBIMBA
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
HealthAid Conergy 30mg capsules
091102000BBFGA0
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
HealthAid Mega CO-Q-10 120mg capsules
091102000BBHBBS
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Higher Nature Co-enzyme Q10 30mg tablets
091102000BBFBBM
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Hunza Health Co-enzyme Q10 30mg capsules
091102000BBIFAI
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Kirkman Coenzyme Q10 25mg chewable tablets
091102000BBIEBL
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Lamberts Co-Enzyme Q10 100mg capsules
091102000BBHWBA
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Lamberts Co-Enzyme Q10 200mg capsules
091102000BBIKBI
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Lamberts Co-Enzyme Q10 30mg capsules
091102000BBHPAI
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Myoquinone 100mg capsules
091102000BBIGBA
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Natures Aid Co-Q-10 100mg capsules
091102000BBIBBA
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Natures Aid Co-Q-10 300mg capsules
091102000BBICBJ
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Natures Aid Co-Q-10 30mg capsules
091102000BBHTAI
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Quest Enzyme Digest tablets
091102000BBACA0
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Superdrug Co-Enzyme Q10 30mg capsules
091102000BBHHAI
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Ubicor 5mg/ml oral drops
091102000BBIDBD
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Valupak Co-Q-10 30mg capsules
091102000BBIHAI
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Valupak Co-Q-10 30mg tablets
091102000BBIVBM
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.